markets
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
DecryptOctober 20, 2026 · 10:34 PM2 min read
The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.
Originally published on Decrypt
The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.
#decrypt
#markets
Community Discussion
No comments yet. Be the first to share your thoughts!